11 – 20 of 168
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reply from Authors re: Bas W.G. van Rhijn, Mark A. Behrendt, Kees Hendricksen, Theo H. van der Kwast. Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.03.030.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
(
- Contribution to journal › Article
-
Mark
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Targeting the Mechanisms of Progression in Castration-resistant Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
EAU Guidelines on Renal Cell Carcinoma: 2014 Update.
(
- Contribution to journal › Article